Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
There’s A New COVID Variant, KP.3 – These Are The Symptoms
IFLScience· 1 day agoKP.3 is one of the FLiRT variants of SARS-CoV-2. The immune system can learn to recognize spike...
Moderna announces good results from trial of combo COVID / flu vaccine
Medical Xpress· 6 days agoThe shot—for now called mRNA-1083—"has met its primary endpoints, eliciting a higher immune response...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
The Arizona Republic· 4 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona....
Past COVID infections may help protect against certain colds
WJZY via Yahoo News· 4 days agoThese vaccines, he said, are “still your best defense against severe COVID-19 infection,...
Are We Headed for Another Summer COVID-19 Wave?
Time via Yahoo News· 4 days agoNationally, the amount of SARS-CoV-2 virus in wastewater is still low, according to the U.S. Centers for Disease Control ...
COVID is coming for Calif., and it's already hitting the Bay Area the hardest
San Francisco Chronicle· 4 days agoIf you or any of your friends have gotten sick with COVID-19 recently, you’re not the only ones:...
Past COVID-19 infection may protect people against some common colds
Euronews via Yahoo News· 4 days agoThese vaccines, he said, are “still your best defence against severe COVID-19 infection,...
Xencor (NASDAQ:XNCR) Price Target Cut to $32.00
ETF DAILY NEWS· 18 hours agoXencor (NASDAQ:XNCR – Get Free Report) had its target price lowered by BMO Capital Markets from $34.00 to $32.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an ...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo News· 3 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines and ...